Aortic stenosis overview: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 203: Line 203:
{{Reflist|2}}
{{Reflist|2}}


[[es:Estenosis aórtica]]
[[Category:Disease]]
[[fr:Rétrécissement aortique]]
[[Category:Signs and symptoms]]
[[pl:Stenoza Aortalnej]]
[[Category:Physical Examination]]
[[pt:Estenose aórtica]]
[[Category:Valvular heart disease]]
[[ro:Stenoza Aortică]]
[[Category:Cardiology]]
[[tr:Aort darlığı]]
[[Category:Congenital heart disease]]
[[Category:Mature chapter]]
[[Category:Cardiac surgery]]
[[Category:Surgery]]
[[Category:Overview complete]]
[[Category:Template complete]]
 
 


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 13:45, 11 October 2012

Aortic Stenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Cardiac Stress Test

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Aortic Valve Area

Aortic Valve Area Calculation

Treatment

General Approach

Medical Therapy

Surgery

Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty

Transcatheter Aortic Valve Replacement (TAVR)

TAVR vs SAVR
Critical Pathway
Patient Selection
Imaging
Evaluation
Valve Types
TAVR Procedure
Post TAVR management
AHA/ACC Guideline Recommendations

Follow Up

Prevention

Precautions and Prophylaxis

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic stenosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic stenosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic stenosis overview

CDC on Aortic stenosis overview

Aortic stenosis overview in the news

Blogs on Aortic stenosis overview

Directions to Hospitals Treating Aortic stenosis overview

Risk calculators and risk factors for Aortic stenosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Mohammed A. Sbeih, M.D. [2]; Lakshmi Gopalakrishnan, M.B.B.S. [3] Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]

Overview

The aortic valve assures that blood moves forward the from the left ventricle into the aorta and that it does not leak backward during diastole. When functioning appropriately, the aortic valve does not impede the flow of blood between the left ventricle and the aorta and it does not leak. Under some circumstances, the aortic valve becomes narrower than normal, impeding the flow of blood. This is known as aortic valve stenosis, or aortic stenosis, often abbreviated as AS.

Classification

Aortic stenosis can be classified broadly in two main categories: acquired and congenital. Further classification can be applied based on the origin of the stenosis such as acquired rheumatic, congenital bicuspid, congenital subaortic, congenital subvalvular, and congenital supravalvular aortic stenosis.

Pathophysiology

The impedance to antegrade blood flow as a result of aortic stenosis results in chronic pressure overload of the left ventricle. The most common complication of aortic stenosis is left ventricular hypertrophy. The obstruction of flow in aortic stenosis can obviously occur at the level of the aortic valve itself, but can also occur at the subvalvular (below the aortic valve) or supravalvular (above the aortic valve) level as well.

Left Ventricular Hypertrophy

Long-standing aortic stenosis exposes the left ventricle to prolonged pressure overload which leads to concentric hypertrophy.[1][2][3] The left ventricular wall increases in thickness (i.e. concentric hypertrophy occurs) as a result of the parallel replication of the sarcomeres.

Diastolic Dysfunction

During the initial period of concentric hypertrophy, the left ventricle is not dilated and there is preservation of left ventricular systolic function. Diastolic function, however, may be reduced due to a reduction in diastolic compliance [4][5][5][6].

This diastolic dysfunction may in turn lead to a rise in pulmonary capillary wedge pressure and dyspnea. Cardiac output may also be reduced as a result of diastolic dysfunction and impaired filling of the left ventricle. Early in the course of aortic stenosis, there may be a failure to augment cardiac output during exercise resulting in dyspnea on exertion.

Systolic Dysfunction

Later in the course of aortic stenosis, left ventricular dysfunction may develop due to a variety of pathophysiology processes. Systolic dysfunction is associated with a poor prognosis, and often does not partially or fully reverse following operative repair[5] .

Excess Hypertrophy Causes Systolic Dysfunction

Although, this massive concentric hypertrophy characterized by a reduced diastolic radius-to-wall thickness ratio has shown to initially counter balance the increased systolic left ventricular pressure, if this process continues, an inverse relationship has been observed such that ejection fraction eventually goes down as left ventricular mass increases beyond a certain point.[7][5][8][9].

Myocardial Ischemia

The hypertrophied left ventricle and the prolonged ejection time (the time for the heart to eject blood) results in increased myocardial oxygen requirements. The elevated diastolic filling pressure also reduces the gradient between the aorta and the right atrium ("the height of the waterfall") that drives coronary blood flow. There may be a relative reduction in the density of the capillary network. The hypertrophied ventricle may also compress the capillaries. All of the above lead to a reduction in coronary blood flow even in the absence of obstructive epicardial stenoses. This may lead to subendocardial ischemia during stress or exercise.[10][11].

Myocardial Fibrosis

Myocardial scarring or fibrosis may develop with prolonged aortic stenosis, perhaps due to chronic subendocardial ischemia or increased wall stress.

Dyssynchronous Contraction

Another factor that may contribute to reduced left ventricular systolic function is dyssynchronous contraction subsequent to regional wall motion abnormalities, fibrosis or ischemia.[12]

Atrial Fibrillation

The stiff, non-compliant left ventricle can become increasingly dependent upon the left atrium for filling. The development of atrial fibrillation and the loss of atrial contractility can result in reduced left ventricular filling and reduced cardiac output.

Epidemiology and Demographics

Aortic stenosis primarily affects older adults and the majority of cases are due to calcific degeneration. Aortic stenosis tends to affect approximately 2% of patients over the age of 65, 3% the age of 75, and 4% over the age 85.[13]

Risk Factors

The most common risk factor for the subsequent development of aortic stenosis arises is a congenital bicuspid aortic valve. Rheumatic fever is a risk factor for the subsequent development of aortic stenosis (rheumatic heart disease). Risk factors that may speed up the progression of degenerative calcific aortic stenosis include:

Causes

Aortic stenosis can be categorized under two methods of causation: acquired and congenital.

Valvular Aortic Stenosis:

Acquired [14]

Congenital [14]

Subvalvular Aortic Stenosis:

Supravalvular Aortic Stenosis:

  • Hypoplasia of aorta
  • Hourglass constriction of aorta
  • Fibromembranous aortic lesion

A complete list of causes in alphabetic order includes the following:

Differential Diagnosis

Aortic stenosis must be differentiated from other cardiac or pulmonary causes of dyspnea, weakness, and dizziness. Furthermore, if there is left ventricular outflow tract obstruction, it is critical to identify if the obstruction is subvalvular, valvular or supravalvular or due to Hypertrophic Cardiomyopathy (HOCM).

Natural History, Complications & Prognosis

Degenerative Calcific Aortic Stenosis

Aortic stenosis due to degeneration of a calcified aortic valve has a prolonged latent period during which time symptoms may be minimal or even lacking [15]. This form of aortic stenosis presents later in life, usually after the age of 75 [16]. The average rate of progression in valvular aortic stenosis, once moderate stenosis is present and symptomatic, is a decrease in valve area of 0.1 cm2 per year [17][15]. Also on average, there is an increase in the jet velocity of 0.3 m / second per year and an increase in the mean pressure gradient of 7 mm Hg per year [18] [19][20]. There is tremendous individual variability in the rate of progression of aortic stenosis. Risk factors for atherosclerosis, such as age, smoking, hypertension, obesity and diabetes, lipid abnormalities, chronic renal failure and dialysis, and atherosclerotic disease itself, such as concomitant coronary artery disease are associated with more rapid rates of aortic stenosis progression.

Aortic Stenosis Due to Rheumatic Heart Disease

These patients generally become symptomatic after the sixth decade.

Bicuspid Aortic Valve Disease

Bicuspid aortic valve stenosis presents one to two decades earlier. The rate of progression of degenerative aortic stenosis can be faster than in those with congenital or rheumatic disease [21]. Bicuspid aortic valve, during childhood functions without any significant pressure gradient. However, the thickening and calcification of the valves may be detectable pathologically and on echocardiography by second decade[22]. This progresses to aortic stenosis requiring operative correction in approximately 75% of cases.[23][24]

Bicuspid aortic stenosis progressively leads to heart failure, arrythmias, angina and other symptoms which generally manifests between 40 to 60 years of age which is relatively younger to manifestation of aortic stenosis otherwise.[23] However, children who develop early pathologic changes in bicuspid aortic valve are more likely to develop aortic insufficiency than stenosis.

Aortic Sclerosis

Aortic sclerosis (defined as aortic valve thickening without obstruction to ventricular outflow) may progress to narrowing of the aortic valve or aortic stenosis. If the pulse pressure or upstroke of the pulse diminishes in the patient with aortic sclerosis, this can be a sign of progression to aortic stenosis.

Complications

Degenerative Calcific Aortic Stenosis

If left untreated, aortic stenosis may lead to complications such as angina, syncope, or heart failure. A complete list of complications of aortic stenosis includes the following:

Bicuspid Aortic Valve Disease

Bicuspid aortic valve disease is associated with the following complications:

Prognosis

Asymptomatic Patients

The prognosis of patients with aortic stenosis who do not have symptoms is quite good [30]. The annual mortality rate is < 1% per year in asymptomatic patients. Only 4% of sudden cardiac deaths that occur in patients with aortic stenosis occur in those patients who are asymptomatic.

Symptomatic Patients

Medical treatment of newly diagnosed moderate to severe symptomatic aortic stenosis is associated with a 25% mortality at one year, and a 50% mortality at two years. Half the deaths are due to sudden cardiac death [31] [32].

Left untreated, the average survival is 5 years after the onset of angina, 3 years after the onset of syncope, and 1 year after the onset of congestive heart failure [31][33][34].

Diagnosis

History and Symptoms

The main symptoms of aortic stenosis include angina, syncope and congestive heart failure. Left untreated, the average survival is 5 years after the onset of angina, 3 years after the onset of syncope, and 1 year after the onset of congestive heart failure [31][33][34]. Other symptoms include dyspnea on exertion, orthopnea and paroxysmal nocturnal dyspnea.

Physical Examination

Aortic stenosis is most often diagnosed when it is asymptomatic and can sometimes be detected during routine examination of the heart and circulatory system. The major signs include pulsus parvus et tardus (a slow-rising, small volume carotid pulse), a lag time between apical and carotid impulses, and a distinct systolic ejection murmur.

Electrocardiogram

The electrocardiogram in the patient with moderate to severe aortic stenosis may reveal left ventricular hypertrophy and heart block.

Chest X-ray

Chest x ray may be used as a diagnostic tool in the evaluation of aortic stenosis. Findings associated with aortic stenosis include left ventricular hypertrophy and calcification of the aortic valve.

MRI

Magnetic resonance imaging is rarely used in the diagnosis of aortic stenosis, except in rare cases where the echocardiographic findings are inconclusive. There is a signal void where the high velocity jet exits the aortic valve.

CT

Computed tomography can be helpful as a diagnostic tool in conditions where the echocardiographic findings are inconclusive.

Echocardiography

Echocardiography is the best non-invasive test to evaluate the aortic valve anatomy and function. Echocardiography can be used to estimate the gradient across the aortic valve using the modified Bernoulli equation (gradient = 4 X velocity2). The flow must be constant, so as the velocity increases, the valve area decreases proportionally. Echocardiography can also be used to assess the severity of left ventricular hypertrophy.

Cardiac Catheterization

Left and right heart catheterization as well as angiography may be useful in the assessment of the patient prior to aortic valve replacement surgery.

Aortic Valve Area

The aortic valve area is the size of the orifice for blood to flow from the left ventricle to the aorta. The aortic valve area is reduced in aortic stenosis, and the aortic valve area is the metric that is used to gauge the need for aortic valve replacement surgery. The pressure gradient across a narrowed aortic valve cannot be used to gauge the need for valve replacement as the gradient may be low in patients with impaired left ventricular function.

Aortic Valve Area Calculation

Aortic valve area calculation is an indirect method of determining the area of the aortic valve. The calculated aortic valve orifice area is currently one of the measures for evaluating the severity of aortic stenosis. A valve area of less than 0.8 cm² is considered to be severe aortic stenosis.[35][36]

There are many ways to calculate the valve area of aortic stenosis. The most commonly used methods involve measurements taken during echocardiography. For interpretation of these values, the area is generally divided by the body surface area, to arrive at the patient's optimal aortic valve orifice area.

Treatment

Once a patient becomes symptomatic with aortic stenosis, aortic valve replacement should be performed. Medical therapy reduces symptoms but does not prolong life. If a patient has extensive co-morbidities, transcatheter aortic valve implantation can be considered. Aortic valvuloplasty can be considered in those patients who are too sick for surgery or transcatheter aortic valve implantation.

Medical Therapy

While medical therapy may improve the symptoms of patients with aortic stenosis, medical therapy does not prolong life expectancy. Aortic valve replacement remains the definitive treatment of symptomatic aortic stenosis and it improves both the symptoms and life expectancy of patients with aortic stenosis. When pharmacological therapies are used, extreme caution must be exercised in the administration of vasodilators as excess vasodilation may lead to hypotension, a reduction in perfusion pressure to the heart, a further decline in cardiac output and further hypotension. This downward spiral can be fatal and must be avoided at all costs.

Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty

Although surgical aortic valve replacement is the mainstay of treatment of aortic stenosis as it improves both symptoms and life expectancy, some patients may not be surgical candidates due to comorbidities, and minimally invasive treatment such as percutaneous aortic balloon valvotomy (PABV) maybe an alternative to surgery as a palliative strategy. PABV is a procedure in which 1 or more balloons are placed across a stenotic valve and inflated to decrease the severity of aortic stenosis. This is to be distinguished from transcatheter aortic valve implantation (TAVI) which is a different method that involves replacement of the valve percutaneously.

Transcatheter aortic valve implantation

Untill recently, aortic valve replacement (AVR) was the only effective treatment for severe symptomatic aortic stenosis. However, over the past decade percutaneous treatment of aortic valve disease with implantation of a stent-based valve prosthesis has been introduced as a new treatment in patients considered inoperable because of severe co-morbidities.[37] In Transcatheter Aortic Valve Implantation (TAVI) also known as Percutaneous Aortic Valve Replacement (PAVR), a synthetic valve is advanced to the heart through a small hole made in groin. This procedure is similar in its mechanism to the insertion of a stent, or performing balloon angioplasty albeit with much larger equipment. Traditional aortic valve replacement is an invasive surgical procedure, with considerable mortality and morbidity, especially in more fragile patients. In the newly developed TAVI procedure, the dysfunctional aortic valve is replaced percutaneously, which obviates the need for open heart surgery.

Surgery

Aortic stenosis requires aortic valve replacement once the patient becomes symptomatic.

Prevention

Aortic stenosis associated with rheumatic heart disease can be minimized with antibiotic therapy in patients with documented streptococcal pharyngitis (strep throat). Bicuspid aortic valve disease is a congenital variant and cannot be prevented. Calcific degeneration of the valve can potentially be minimized by rosouvistatin and other measures targeting atherosclerosis prevention.

Precautions and Prophylaxis

People with aortic stenosis of any etiology are at risk for the development of infection of their stenosed valve, i.e. infective endocarditis and antibiotic prophylaxis should be considered. Patients with severe aortic stenosis should avoid strenuous exercise and any exercise that greatly increases afterload such as weight lifting.

References

  1. ↑ Sasayama S, Ross J, Franklin D, Bloor CM, Bishop S, Dilley RB (1976). "Adaptations of the left ventricle to chronic pressure overload". Circulation Research. 38 (3): 172–8. PMID 129304. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  2. ↑ Gaasch WH (1979). "Left ventricular radius to wall thickness ratio". The American Journal of Cardiology. 43 (6): 1189–94. PMID 155986. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  3. ↑ Spann JF, Bove AA, Natarajan G, Kreulen T (1980). "Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis". Circulation. 62 (3): 576–82. PMID 6446989. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  4. ↑ Gaasch WH, Levine HJ, Quinones MA, Alexander JK (1976). "Left ventricular compliance: mechanisms and clinical implications". The American Journal of Cardiology. 38 (5): 645–53. PMID 136186. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  5. ↑ 5.0 5.1 5.2 5.3 Murakami T, Hess OM, Gage JE, Grimm J, Krayenbuehl HP. [[]] http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=2938847. Retrieved 2012-04-10. Unknown parameter |month= ignored (help); Missing or empty |title= (help)
  6. ↑ Gaasch WH (1994). "Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction". JAMA : the Journal of the American Medical Association. 271 (16): 1276–80. PMID 8151903. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  7. ↑ Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H (1988). "Left ventricular systolic function in aortic stenosis". European Heart Journal. 9 Suppl E: 19–23. PMID 2969811. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  8. ↑ Gunther S, Grossman W (1979). "Determinants of ventricular function in pressure-overload hypertrophy in man". Circulation. 59 (4): 679–88. PMID 154367. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  9. ↑ Huber D, Grimm J, Koch R, Krayenbuehl HP (1981). "Determinants of ejection performance in aortic stenosis". Circulation. 64 (1): 126–34. PMID 7237709. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  10. ↑ Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL (1982). "Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries". N Engl J Med. 307 (22): 1362–6. doi:10.1056/NEJM198211253072202. PMID 6215582.
  11. ↑ Carabello BA (2002). "Clinical practice. Aortic stenosis". N Engl J Med. 346 (9): 677–82. doi:10.1056/NEJMcp010846. PMID 11870246.
  12. ↑ Jin XY, Pepper JR, Gibson DG (1996). "Effects of incoordination on left ventricular force-velocity relation in aortic stenosis". Heart (British Cardiac Society). 76 (6): 495–501. PMC 484601. PMID 9014797. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  13. ↑ Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM (1997). "Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study". Journal of the American College of Cardiology. 29 (3): 630–4. PMID 9060903. Retrieved 2012-04-11. Unknown parameter |month= ignored (help)
  14. ↑ 14.0 14.1 Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003). "The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis". European Heart Journal. 24 (5): 442–63. PMID 12633546. Retrieved 2012-04-11. Unknown parameter |month= ignored (help)
  15. ↑ 15.0 15.1 Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH (1996). "Progression of valvular aortic stenosis in adults: literature review and clinical implications". Am Heart J. 132 (2 Pt 1): 408–17. PMID 8701905.
  16. ↑ Townsend CM, et al. Sabiston Textbook of Surgery. 18th ed. Saunders; 2008:1841-1844.
  17. ↑ Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA; et al. (2003). "Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography". J Am Soc Echocardiogr. 16 (7): 777–802. doi:10.1016/S0894-7317(03)00335-3. PMID 12835667.
  18. ↑ Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA, Bode RS (1979). "Rate of progression of severity of valvular aortic stenosis in the adult". Am Heart J. 98 (6): 689–700. PMID 495418.
  19. ↑ Jonasson R, Jonsson B, Nordlander R, Orinius E, Szamosi A (1983). "Rate of progression of severity of valvular aortic stenosis". Acta Med Scand. 213 (1): 51–4. PMID 6829320.
  20. ↑ Peter M, Hoffmann A, Parker C, Lüscher T, Burckhardt D (1993). "Progression of aortic stenosis. Role of age and concomitant coronary artery disease". Chest. 103 (6): 1715–9. PMID 8404089.
  21. ↑ Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M; et al. (2000). "Predictors of outcome in severe, asymptomatic aortic stenosis". N Engl J Med. 343 (9): 611–7. doi:10.1056/NEJM200008313430903. PMID 10965007.
  22. ↑ Beppu S, Suzuki S, Matsuda H, Ohmori F, Nagata S, Miyatake K (1993). "Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves". The American Journal of Cardiology. 71 (4): 322–7. PMID 8427176. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  23. ↑ 23.0 23.1 23.2 Fenoglio JJ, McAllister HA, DeCastro CM, Davia JE, Cheitlin MD (1977). "Congenital bicuspid aortic valve after age 20". The American Journal of Cardiology. 39 (2): 164–9. PMID 835475. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  24. ↑ 24.0 24.1 24.2 Lewin MB, Otto CM (2005). "The bicuspid aortic valve: adverse outcomes from infancy to old age". Circulation. 111 (7): 832–4. doi:10.1161/01.CIR.0000157137.59691.0B. PMID 15723989. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  25. ↑ Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F; et al. (2003). "Acquired von Willebrand syndrome in aortic stenosis". N Engl J Med. 349 (4): 343–9. doi:10.1056/NEJMoa022831. PMID 12878741.
  26. ↑ Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG (2000). "Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions". Circulation. 102 (19 Suppl 3): III35–9. PMID 11082359. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  27. ↑ Roberts WC, Morrow AG, McIntosh CL, Jones M, Epstein SE (1981). "Congenitally bicuspid aortic valve causing severe, pure aortic regurgitation without superimposed infective endocarditis. Analysis of 13 patients requiring aortic valve replacement". The American Journal of Cardiology. 47 (2): 206–9. PMID 7468467. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  28. ↑ Gersony WM, Hayes CJ, Driscoll DJ, Keane JF, Kidd L, O'Fallon WM, Pieroni DR, Wolfe RR, Weidman WH (1993). "Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect". Circulation. 87 (2 Suppl): I121–6. PMID 8425318. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  29. ↑ Keane JF, Driscoll DJ, Gersony WM, Hayes CJ, Kidd L, O'Fallon WM, Pieroni DR, Wolfe RR, Weidman WH (1993). "Second natural history study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis". Circulation. 87 (2 Suppl): I16–27. PMID 8425319. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  30. ↑ Lancellotti P, Magne J, Donal E, et al. Clinical outcome in asymptomatic severe aortic stenosis insights from the new proposed aortic stenosis grading classification. J Am Coll Cardiol. Jan 17 2012;59(3):235-43.
  31. ↑ 31.0 31.1 31.2 Ross J, Braunwald E (1968). "Aortic stenosis". Circulation. 38 (1 Suppl): 61–7. PMID 4894151.
  32. ↑ Chizner MA, Pearle DL, deLeon AC (1980). "The natural history of aortic stenosis in adults". Am Heart J. 99 (4): 419–24. PMID 7189084.
  33. ↑ 33.0 33.1 Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS (1988). "Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis". Am J Cardiol. 61 (1): 123–30. PMID 3337000.
  34. ↑ 34.0 34.1 Iivanainen AM, Lindroos M, Tilvis R, Heikkilä J, Kupari M (1996). "Natural history of aortic valve stenosis of varying severity in the elderly". Am J Cardiol. 78 (1): 97–101. PMID 8712130.
  35. ↑ Charlson E, Legedza A, Hamel M (2006). "Decision-making and outcomes in severe symptomatic aortic stenosis". J Heart Valve Dis. 15 (3): 312–21. PMID 16784066.
  36. ↑ "Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged >/=80 years". Eur J Cardiothorac Surg. PMID 16950629.
  37. ↑ Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW (2006). "Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study". Circulation. 114 (15): 1616–24. doi:10.1161/CIRCULATIONAHA.106.639450. PMID 17015786. Retrieved 2011-03-17. Unknown parameter |month= ignored (help)


Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Aortic_stenosis_overview&oldid=771667"